BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24998544)

  • 1. Vitamin D receptor BsmI polymorphism and colorectal cancer risk: an updated analysis.
    Yu K; Yang J; Jiang Y; Song R; Lu Q
    Asian Pac J Cancer Prev; 2014; 15(12):4801-7. PubMed ID: 24998544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
    Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
    Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSTP1 Ala114Val polymorphism and colorectal cancer risk: a meta-analysis.
    Li F; Xu B; Yang Z; Wu Y; Dong S; Qian J
    Tumour Biol; 2013 Jun; 34(3):1825-31. PubMed ID: 23504587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BsmI polymorphism of vitamin D receptor gene and cancer risk: a comprehensive meta-analysis.
    Raimondi S; Pasquali E; Gnagnarella P; Serrano D; Disalvatore D; Johansson HA; Gandini S
    Mutat Res; 2014 Nov; 769():17-34. PubMed ID: 25771722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects.
    Guo Z; Wen J; Kan Q; Huang S; Liu X; Sun N; Li Z
    Tumour Biol; 2013 Oct; 34(5):3189-200. PubMed ID: 23807674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor BsmI polymorphism may be associated with an decreased osteoporosis risk in South China.
    An M; Song XB; Chen XY
    Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):50-54. PubMed ID: 28719357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies.
    Jia F; Sun RF; Li QH; Wang DX; Zhao F; Li JM; Pu Q; Zhang ZZ; Jin Y; Liu BL; Xiong Y
    Genet Test Mol Biomarkers; 2013 Jan; 17(1):30-4. PubMed ID: 23134477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.
    Xie Y; Liu GQ; Miao XY; Liu Y; Zhou W; Zhong DW
    Tumour Biol; 2012 Jun; 33(3):809-16. PubMed ID: 22190224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor levels in colorectal cancer. Possible role of BsmI polymorphism.
    Parisi E; Reñé JM; Cardús A; Valcheva P; Piñol-Felis C; Valdivielso JM; Fernández E
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):87-90. PubMed ID: 18583126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Start codon FokI and intron 8 BsmI variants in the vitamin D receptor gene and susceptibility to colorectal cancer.
    Mahmoudi T; Karimi K; Mohebbi SR; Fatemi SR; Zali MR
    Mol Biol Rep; 2011 Oct; 38(7):4765-70. PubMed ID: 21132374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.
    Mei Q; Zhou D; Han J; Lu H; Tang B
    Metabolism; 2012 Sep; 61(9):1321-9. PubMed ID: 22459615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
    Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
    PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population.
    Alkhayal KA; Awadalia ZH; Vaali-Mohammed MA; Al Obeed OA; Al Wesaimer A; Halwani R; Zubaidi AM; Khan Z; Abdulla MH
    PLoS One; 2016; 11(6):e0155236. PubMed ID: 27309378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic polymorphisms in vitamin D receptor and the risk of type 2 diabetes mellitus: an updated meta-analysis.
    Yu F; Cui LL; Li X; Wang CJ; Ba Y; Wang L; Li J; Li C; Dai LP; Li WJ
    Asia Pac J Clin Nutr; 2016; 25(3):614-24. PubMed ID: 27440697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis.
    Jiang O; Zhou R; Wu D; Liu Y; Wu W; Cheng N
    Tumour Biol; 2013 Apr; 34(2):1215-24. PubMed ID: 23355335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ApaI and BsmI polymorphisms with vitiligo risk: a meta-analysis.
    Li L; Wu Y; Li L; Cai YF; Geng L; Gao XH; Chen HD
    Clin Exp Dermatol; 2015 Oct; 40(7):794-803. PubMed ID: 25788285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations study of vitamin D receptor gene polymorphisms with diabetic microvascular complications: a meta-analysis.
    Liu Z; Liu L; Chen X; He W; Yu X
    Gene; 2014 Aug; 546(1):6-10. PubMed ID: 24862218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vitamin D receptor BsmI gene polymorphism and periodontitis: a meta-analysis in a single ethnic group.
    Cai T; Yang ZY; Nie L; Zhen JX; Deng L; Zhou Z
    Cell Mol Biol (Noisy-le-grand); 2017 Nov; 63(11):1-4. PubMed ID: 29208185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21 Ser31Arg polymorphism and cervical cancer risk: a meta-analysis.
    Li Y; Liu F; Tan S; Li S
    Int J Gynecol Cancer; 2011 Apr; 21(3):445-51. PubMed ID: 21430453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.